Corvus Pharmaceuticals, Inc.

CRVS

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001626971

SEC filings (opens in a new tab)

No open-market purchases or sales by Corvus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 173 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Corvus Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of CRVS: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Q3 2023	Change
Holders	52	52	0
Shares	19.5M	19.2M	−305.7K (−1.6%)
Value	$44.6M	$28.0M	−$16.6M (−37.2%)

New holders (10)

Institutions that held Corvus Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to CRVS in Q3 2023
Institution	Shares	Value	% of portfolio
Millennium Management LLC	108,024	$157.7K	0.00%
Group One Trading, L.P.	27,099	$39.6K	0.00%
XTX Topco Ltd	19,244	$28.1K	0.00%
American Century Companies Inc	18,754	$27.4K	0.00%
HRT Financial LP	13,050	$19.0K	0.00%
Gillespie Robinson & Grimm Inc	11,480	$16.8K	0.00%
Two Sigma Securities, LLC	11,232	$16.4K	0.00%
Masso Torrence Wealth Management Inc.	10,000	$14.6K	0.01%
FMR LLC	1,101	$1.61K	0.00%
Citadel Advisors LLC	183	$267	0.00%

Sold out (10)

Institutions that held Corvus Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of CRVS in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Artal Group S.A.	500,000	$1.15M
CHI Advisors LLC	200,000	$458.0K
Cornercap Investment Counsel Inc	97,248	$222.7K
Acadian Asset Management LLC	58,069	$132.0K
Jane Street Group, LLC	35,118	$80.4K
Squarepoint Ops LLC	17,082	$39.1K
Cubist Systematic Strategies, LLC	15,552	$35.6K
Tucker Asset Management LLC	12,871	$29.5K
Difesa Capital Management, LP	10,000	$22.9K
NewSquare Capital LLC	220	$504